A Prospective 12-week Randomized Controlled Trial of Remotely-Delivered Customized Adherence Enhancement for Poorly Adherent Individuals with Schizophrenia vs Enhanced Treatment as Usual
Telehealth CAE-S is feasible and acceptable among poorly adherent patients with schizophrenia. Adherence improved rapidly with monitoring, which could explain improvement in schizophrenia symptoms and largely similar outcomes across intervention arms.
Authors
- Jacqueline Krehel-Montgomery
- Nicole M. Fiorelli (ORCID: https://orcid.org/0009-0005-2040-5683)
- Jennifer B. Levin
- Sakshi Priya
- Martha Sajatovic
- Farren Briggs
- Jessica Surdam
- Gracie Howard-Griggs
Institutions
- University of Miami (US)
- University Hospitals of Cleveland (US)
Publication Details
- Journal
- Psychopharmacology Bulletin
- Published
- 2025-12-22
- DOI
- https://doi.org/10.64719/pb.15412
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00